Publication |
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients. Feldheim J, Wend D, Lauer MJ, Monoranu CM, Glas M, Kleinschnitz C, Ernestus RI, Braunger BM, Meybohm P, Hagemann C, Burek M. Int J Mol Sci. 2022 Jul 22;23(15):8101. doi: 10.3390/ijms23158101.
|
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells. Feldheim J, Kessler AF, Feldheim JJ, Schulz E, Wend D, Lazaridis L, Kleinschnitz C, Glas M, Ernestus RI, Brandner S, Monoranu CM, Löhr M, Hagemann C. Int J Mol Sci. 2022 May 7;23(9):5238. doi: 10.3390/ijms23095238.
|
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies. Feldheim J, Deuschl C, Glas M, Kleinschnitz C, Hagenacker T. Neurol Res Pract. 2021 May 24;3(1):30. doi: 10.1186/s42466-021-00129-w.
|
Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients. Kessler AF, Feldheim J, Schmitt D, Feldheim JJ, Monoranu CM, Ernestus RI, Löhr M, Hagemann C.
|
Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma-A New Disease Biomarker? Feldheim J, Kessler AF, Schmitt D, Salvador E, Monoranu CM, Feldheim JJ, Ernestus RI, Löhr M, Hagemann C. Cancers (Basel). 2020 Apr 27;12(5). pii: E1085. doi: 10.3390/cancers12051085.
|
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model. Curtaz CJ, Schmitt C, Herbert SL, Feldheim J, Schlegel N, Gosselet F, Hagemann C, Roewer N, Meybohm P, Wöckel A, Burek M. Fluids Barriers CNS. 2020 Apr 22;17(1):31. doi: 10.1186/s12987-020-00192-6.
|
Changes of O6-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse-A Meta-Analysis Type Literature Review. Feldheim J, Kessler AF, Monoranu CM, Ernestus RI, Löhr M, Hagemann C. Cancers (Basel). 2019 Nov 21;11(12). pii: E1837. doi: 10.3390/cancers11121837. Review.
|
Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients. Feldheim J, Kessler AF, Schmitt D, Wilczek L, Linsenmann T, Dahlmann M, Monoranu CM, Ernestus RI, Hagemann C, Löhr M. Onco Targets Ther. 2018 Dec 4;11:8673-8684. doi: 10.2147/OTT.S176549. eCollection 2018.
|
|
| Last update Publications 05.01.2023 |
|